Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPremier Foods Regulatory News (PFD)

Share Price Information for Premier Foods (PFD)

Share Price is delayed by 15 minutes
Get Live Data
198.70    1.50 (0.76%)
Bid:
197.70
Ask:
198.00
Spread: 0.30 (0.152%)
Market Cap: £1.71b
PFD Live PriceLast checked at - London Stock Exchange

Intraday Premier Foods Share Chart

Directorate Change

14 Mar 2018 13:53

RNS Number : 7373H
Premier Foods plc
14 March 2018
 

 

 

Premier Foods plc ("Premier Foods" or the "Company")

14 March 2018

 

Board Retirement

 

Premier Foods announces that Tsunao Kijima, non-executive director, has advised the Company today that he intends to stand down as a director of Premier Foods on 23 March 2018, following his decision to retire from Nissin Foods Holdings Company Ltd ("Nissin"). Mr Kijima has served on the Board since July 2016 pursuant to the terms of the Relationship Agreement between the Company and Nissin.

 

Board Appointment

 

Following Mr Kijima's retirement, Shinji Honda will be appointed as a non-executive director and as Nissin's representative director pursuant to the Relationship Agreement, with effect from 23 March 2018.

 

Mr Honda is Chief Strategy Officer of Nissin, with responsibility for overseas operations, including Europe. Prior to joining Nissin in January 2018, Mr Honda spent his entire professional career at Takeda Pharmaceutical Company Limited ("Takeda"), a leading Japanese pharmaceutical company. He was named Member of the Board of Takeda in June 2013 and Corporate Strategy Officer in October 2014, having previously spent a significant amount of time overseeing Takeda's international operations where his responsibilities included President and CEO of Takeda North America.

 

Commenting on the changes Keith Hamill, Chairman of Premier Foods, said "I would like to take this opportunity to thank Mr Kijima for his significant contribution to both the Board and the partnership between Premier and Nissin, which has helped to ensure the successful launch of a number of exciting new products to market. We welcome Mr Honda to the Board and look forward to working with him in the future".

 

Mr Honda served as Member of the Board of Takeda Pharmaceutical Company Limited (listed on the first section of the Tokyo Stock Exchange) from June 2013 until June 2017. No further information is required to be disclosed pursuant to LR 9.6.13 R.

For further information please contact:

Andrew McDonald, General Counsel & Company Secretary +44 (0) 1727 815 850

Hannah Collyer, Corporate Affairs Director +44 (0) 1727 815 850

Richard Godden, Director of Investor Relations +44 (0) 1727 815 850

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAXZLFFVXFEBBF
Date   Source Headline
4th Sep 201511:03 amRNSChange of Auditor
1st Sep 201511:01 amRNSTotal Voting Rights
3rd Aug 20159:28 amRNSTotal Voting Rights
24th Jul 20154:58 pmRNSDirector/PDMR Shareholding
23rd Jul 20154:26 pmRNSResult of AGM
23rd Jul 20157:00 amRNSTrading Statement
9th Jul 20157:00 amRNSNotification of Trading update and AGM
1st Jul 20154:42 pmRNSDirector/PDMR Shareholding
1st Jul 201510:30 amRNSTotal Voting Rights
1st Jul 20157:00 amRNSAnalyst & Investor visit
12th Jun 20154:22 pmRNSDirector/PDMR Shareholding
9th Jun 20152:55 pmRNSDirector/PDMR Shareholding
9th Jun 20159:02 amRNSAnnual Financial Report
1st Jun 20159:49 amRNSTotal Voting Rights
29th May 20153:08 pmRNSDirector/PDMR Shareholding
26th May 20159:26 amRNSDirector/PDMR Shareholding
19th May 20154:42 pmRNSDirector/PDMR Shareholding
19th May 20157:00 amRNSFinal Results
7th May 20154:12 pmRNSDirectorate Change
6th May 20159:00 amRNSNotice of Results
1st May 20159:52 amRNSTotal Voting Rights
2nd Apr 20154:31 pmRNSDirector/PDMR Shareholding
1st Apr 20154:07 pmRNSDirector/PDMR Shareholding
1st Apr 20151:33 pmRNSBlocklisting Interim Review
1st Apr 20159:36 amRNSTotal Voting Rights
20th Mar 20157:00 amRNSHolding(s) in Company
2nd Mar 20159:42 amRNSTotal Voting Rights
25th Feb 20154:11 pmRNSDirector/PDMR Shareholding
2nd Feb 201511:21 amRNSTotal Voting Rights
26th Jan 20158:58 amRNSDirector/PDMR Shareholding
23rd Jan 20157:00 amRNSTrading Statement
16th Jan 201512:30 pmRNSNotification of Management Statement
13th Jan 20159:22 amRNSHolding(s) in Company
6th Jan 201510:00 amRNSDirectorate Change
2nd Jan 20159:35 amRNSTotal Voting Rights
17th Dec 201410:30 amRNSHolding(s) in Company
15th Dec 201411:00 amRNSDirector/PDMR Shareholding
11th Dec 20149:20 amRNSHolding(s) in Company
1st Dec 20149:41 amRNSTotal Voting Rights
20th Nov 20149:23 amRNSDirector Declaration
13th Nov 201412:15 pmRNSDirector/PDMR Shareholding
7th Nov 201410:22 amRNSHolding(s) in Company
3rd Nov 20143:29 pmRNSTotal Voting Rights
31st Oct 20149:12 amRNSApplication for Block Listing
27th Oct 20149:23 amRNSDirector/PDMR Shareholding
23rd Oct 20147:00 amRNSInterim Management Statement
15th Oct 20143:26 pmRNSApproval of Share Incentive Plan
3rd Oct 20144:28 pmRNSDirector/PDMR Shareholding
2nd Oct 20142:53 pmRNSDirector/PDMR Shareholding
1st Oct 20142:09 pmRNSBlocklisting Interim Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.